Search - Prime Therapeutics
-
publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...
-
Joseph Leach, M.D., senior vice president and chief medical officer at Prime Therapeutics/Magellan Rx Management, shares more about the RTBC electronic prescription decision support tool
PA Sub-Categories: Technology Products Prime Article: Perspectives -
Benefit from effective medication management Promote appropriate medication use, decrease waste and connect the entire care journey with our GuidedHealth® solutions. Breadcrumb Home Our solutions...
-
Nondiscrimination & Languages Prime Therapeutics (Prime) complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability...